Vir Biotechnology Management
Management criteria checks 1/4
Vir Biotechnology's CEO is Marianne De Backer, appointed in Apr 2023, has a tenure of 1.08 years. total yearly compensation is $39.49M, comprised of 1.7% salary and 98.3% bonuses, including company stock and options. directly owns 0.052% of the company’s shares, worth $689.13K. The average tenure of the management team and the board of directors is 1.7 years and 6.3 years respectively.
Key information
Marianne De Backer
Chief executive officer
US$39.5m
Total compensation
| CEO salary percentage | 1.7% |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.05% |
| Management average tenure | 1.7yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Boosting Their Estimates
May 05
Vir Biotechnology Provides Some Hope For Its Beleaguered Shareholders
May 03Vir Biotechnology: Making Progress In Hepatitis B And Hepatitis Delta
Feb 28Sticking With Vir Biotechnology
Jan 17Vir Biotechnology, Inc. (NASDAQ:VIR) Analysts Just Slashed This Year's Revenue Estimates By 37%
Aug 07Revenues Working Against Vir Biotechnology, Inc.'s (NASDAQ:VIR) Share Price Following 42% Dive
Jul 24Analysts Just Shaved Their Vir Biotechnology, Inc. (NASDAQ:VIR) Forecasts Dramatically
Feb 28Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Could Be 26% Below Their Intrinsic Value Estimate
Jan 07Vir Biotechnology: Focus On Hepatitis B Development Could End Up Paying Off
Oct 12Vir Biotech gains 12% as U.S. govt. inks multi-year deal worth up to $1B
Oct 04Vir begins dosing in mid-stage study of VIR-2218, VIR-3434 for hepatitis D virus
Sep 22Vir Biotechnology falls 15% on Q2 revenue miss impacted by ~$400M for potential write-offs
Aug 09Vir: Biotechnology's Best Near-Term Capital Gain Prospect
Jul 27Vir Biotechnology announces transition of chief scientific officer
Jul 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$539m |
| Dec 31 2023 | US$39m | US$675k | -US$615m |
Compensation vs Market: Marianne's total compensation ($USD39.49M) is above average for companies of similar size in the US market ($USD5.66M).
Compensation vs Earnings: Insufficient data to compare Marianne's compensation with company performance.
CEO
Marianne De Backer (54 yo)
1.1yrs
Tenure
US$39,491,495
Compensation
Dr. Marianne De Backer, MSc, Ph. D. MBA, served as Independent Director at Kronos Bio, Inc. from January 25, 2021 to June 2023. Dr. De Backer served as Executive Vice President, Head of Global Business Dev...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | US$39.49m | 0.052% $ 689.1k | |
| Executive VP & Chief Technology Officer | 3.2yrs | US$3.11m | 0.029% $ 384.7k | |
| Executive VP & Chief Business Officer | less than a year | US$4.54m | 0.00023% $ 3.0k | |
| Co-Founder & Scientific Advisor | 8.3yrs | US$177.66k | no data | |
| Co-Founder & Scientific Advisor | 8.3yrs | no data | no data | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Executive VP & Chief Scientific Officer | less than a year | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Executive VP | 1.7yrs | no data | no data | |
| Vice President of Corporate Communications | no data | no data | no data | |
| Executive VP & Chief Human Resources Officer | less than a year | no data | no data | |
| SVP & Senior Research Fellow | 6.4yrs | no data | no data |
1.7yrs
Average Tenure
62yo
Average Age
Experienced Management: VIR's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | US$39.49m | 0.052% $ 689.1k | |
| Co-Founder & Scientific Advisor | 5.3yrs | US$177.66k | no data | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Independent Director | 8.1yrs | US$454.90k | 0.44% $ 5.9m | |
| Independent Director | 7.7yrs | US$474.90k | 0.024% $ 316.4k | |
| Independent Chairman | 7.4yrs | US$502.26k | 0.96% $ 12.7m | |
| Director | 7.3yrs | US$688.20k | 2.75% $ 36.3m | |
| Scientific Advisor | 5.3yrs | US$23.92k | no data | |
| Independent Director | 7.3yrs | US$459.90k | 0.0072% $ 94.8k | |
| Independent Director | 3.4yrs | US$472.17k | 0.0072% $ 94.8k | |
| Independent Director | 4.7yrs | US$476.51k | 0.0034% $ 44.6k |
6.3yrs
Average Tenure
63yo
Average Age
Experienced Board: VIR's board of directors are considered experienced (6.3 years average tenure).